Copenhagen Pharma Consulting ApS: Financial statements 2025
CVR: 41537388
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Copenhagen Pharma Consulting ApS (CVR 41537388) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. That is an increase of 28.5% compared with the year before. Equity in the 2025 report amounted to DKK 601,867. The solvency ratio was 41.4%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,364,006
- Profit/Loss
- DKK 419,568
- Equity
- DKK 601,867
- Total Assets
- DKK 1,455,343
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 3.4M | 420K | 602K | 2 |
| 2024 | - | 2.6M | 558K | 1.7M | 2 |
| 2023 | - | 2.9M | 336K | 1.2M | 2 |
| 2022 | - | 1.3M | -38K | 906K | 2 |
Official annual report
How creditworthy is Copenhagen Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Copenhagen Pharma Consulting ApS has published its annual report for 2024. Gross profit came to DKK 2,617,035, and the net result was DKK 558,252.
About Copenhagen Pharma Consulting ApS
Copenhagen Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2020. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lars Holten-Andersen. The company is owned by Obi1 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. Equity in the 2025 report amounted to DKK 601,867.
